[ADAR1调节ERK/c-FOS/MMP-9通路,驱动非小细胞肺癌细胞的增殖和迁移]
Li Zhang1,2, Xue Pan1, Wenqing Yan1
1Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
Zhongguo fei ai za zhi = Chinese journal of lung cancer
|November 27, 2025
概括
高ADAR1表达与非小细胞肺癌 (NSCLC) 的预后不佳相关. ADAR1通过ERK/c-FOS/MMP-9通路促进瘤生长和转移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 双链RNA特异性腺脱氨酶1 (ADAR1) 是一种参与RNA编辑的酶.
- 它在非小细胞肺癌 (NSCLC) 病原发生中的确切作用尚未完全理解.
研究的目的:
- 研究ADAR1在NSCLC中的预后意义.
- 阐明ADAR1在调节瘤细胞增殖和迁移中的作用.
主要方法:
- 对ADAR1表达和患者预后的TCGA和cBioPortal数据的分析.
- 在体外测定 (西部污点,扩散,Transwell入侵/迁移) 和体内异种移植模型.
- 在肺癌细胞系中进行ADAR1倒置和过度表达研究.
主要成果:
- 在肺腺癌和状细胞癌组织中,ADAR1的调节显著上升.
- 高ADAR1表达与预后不佳和远程转移有关.
- 抑制ADAR1 knockdown抑制了扩散,入侵,迁移和瘤发生,与减少ERK/c-FOS/MMP-9信号相关.
结论:
- 过高的ADAR1表达是NSCLC预后不佳和转移的标志物.
- ADAR1通过ERK/c-FOS/MMP-9信号轴促进肺癌的进展.
相关概念视频
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K


